FOLH1 and neoplasm: In the light of PSMA-based RLT, the total tumor volume (TTV), as derived from PSMA PET/CT, has shown to be a feasible tool for evaluation of treatment response [17], as also recently underlined in a consensus statement by the EANM [18].